Marketwatch Biocon’s partner Mylan receives favourable ruling for device in U.S. Admin June 1, 2020 Clears hurdle for patenting Biocon’s Insulin Glargine. – The Hindu – Industry Share on Facebook Tweet it Pin it Share it Email